History and exam

Your Organizational Guidance

ebpracticenet urges you to prioritize the following organizational guidance:

Évaluation du risque cardiovasculaire en première lignePublished by: Domus MedicaLast published: 2010Cardiovasculaire risicobepaling in de eerste lijnPublished by: Domus MedicaLast published: 2020

Key diagnostic factors

common

family history of early onset of coronary heart disease or dyslipidemia in first-degree relatives

Given the paucity of early signs and symptoms of hypercholesterolemia, it is crucial to perform a thorough family history. A significant family history (for example, of early onset coronary heart disease [e.g., occurring in male first-degree relatives under 55 years old and in female first-degree relatives under 60-65 years old]) suggests primary hypercholesterolemia.[41][44]

history of cardiovascular disease

Most patients with hypercholesterolemia are not diagnosed until premature cardiovascular disease becomes symptomatic.

It is important to assess lipid profiles in patients presenting with angina, myocardial infarction, stroke, and peripheral vascular disease.

consumption of saturated fats and trans-fatty acids

Sedentary lifestyle and a diet characterized by excessive consumption of saturated fats and trans-fatty acids.[14]

excess body weight (especially abdominal obesity)

A body mass index >25 kg/m² and a waist circumference that is >94 cm in white and black men, >80 cm in white and black women, >90 cm in Asian men, and >80 cm in Asian women is associated with a variety of unfavorable changes in lipid metabolism.[23][24]​​

xanthelasmas

Yellow plaques that occur most commonly near the inner canthus of the eyelid.[Figure caption and citation for the preceding image starts]: Extravascular lipid deposits (xanthelasma) (arrows) in a patient treated with margarine enriched in plant sterolsVergès B, Athias A, Petit J-M, et al. Extravascular lipid deposit (xanthelasma) induced by a plant sterol-enriched margarine. BMJ Case Reports. 2009;2009:bcr10.2008.1108 [Citation ends].com.bmj.content.model.Caption@3a67900c

Half of these lesions are associated with elevated plasma lipid levels.[45]

Some occur with altered lipoprotein composition or structure, such as lowered high-density lipoprotein cholesterol levels.

They frequently occur in patients with type II and IV hyperlipidemia.

uncommon

tendinous xanthomas

Slowly enlarging subcutaneous nodules related to the tendons or the ligaments.

The extensor tendons of the hands, feet, and Achilles tendons are the most common locations. A relationship to previous trauma to the site often exists.[Figure caption and citation for the preceding image starts]: Xanthomata over the metacarpophalangeal jointsCenter for Preventive Cardiology, University of Maryland Medical Center [Citation ends].com.bmj.content.model.Caption@7218896b[Figure caption and citation for the preceding image starts]: Xanthomata of the Achilles tendonCenter for Preventive Cardiology, University of Maryland Medical Center [Citation ends].com.bmj.content.model.Caption@28ca1529

Associated with severe hypercholesterolemia and elevated low-density lipoprotein cholesterol levels (familial hypercholesterolemia). They are also associated with some of the secondary hyperlipidemias, such as cholestasis.

Other diagnostic factors

uncommon

arcus cornealis with onset before the age of 45 years

White or gray opaque ring in the corneal margin.

The result of cholesterol deposits in the hyalinosis of the corneal stroma; can be seen in patients with ocular defects or familial hyperlipidemia.

tuberous xanthomas

Firm, painless, red-yellow nodules.

Multilobulated tumors can develop once individual lesions coalesce.

Usually related to pressure areas, such as the extensor surfaces of the knees, elbows, and buttocks.

Particularly associated with hypercholesterolemia and increased levels of low-density lipoprotein. They can be associated with familial dysbetalipoproteinemia and familial hypercholesterolemia, and they may be present in some of the secondary hyperlipidemias.

Risk factors

strong

insulin resistance and type 2 diabetes mellitus

Hypercholesterolemia due to increased very low-density lipoprotein cholesterol (VLDL-C) and expressed by high total cholesterol and non-high-density lipoprotein cholesterol (non-HDL-C) but not low-density lipoprotein cholesterol (LDL-C) can be seen in the context of mixed dyslipidemia, and is associated with insulin resistance.[21]

LDL-C levels are not increased in insulin resistance. However, the number of apoB-containing lipoproteins, such as VLDL-C, is increased. HDL-C and the number of apoA-I particles are usually reduced in insulin resistance. A correlation exists between severity of insulin resistance and degree of lipoprotein abnormalities: greater degrees of insulin resistance are associated with increased VLDL production, reduced clearance, larger VLDL particles, and smaller LDL and HDL particles.[22]

The total number of LDL, intermediate-density lipoprotein, and VLDL particles is also increased in patients with insulin resistance.

excess body weight (body mass index >25 kg/m²)

Weight gain is associated with increased low-density lipoprotein (LDL) cholesterol levels. However when abdominal obesity is present, it is associated with a variety of unfavorable changes in lipid metabolism, similar to those found in insulin resistance and type 2 diabetes.[22][23]​ This includes a waist circumference that is >94 cm in white and black men, >80 cm in white and black women, >90 cm in Asian men, and >80 cm in Asian women.[23][24]

Loss of body fat may partially reverse hypercholesterolemia and hypertriglyceridemia.

hypothyroidism

In a study of patients with primary hypothyroidism, 56% had isolated hypercholesterolemia and another 34% had combined hypercholesterolemia with hypertriglyceridemia.[28]

In another study of patients referred to a lipid disorder specialty clinic, the rate of overt hypothyroidism was found to be 2.8%, and 4.4% of patients had subclinical hypothyroidism.[29]

The severity of lipid abnormalities increases with the severity of the hypothyroidism.

Because of this association, it is appropriate to assess thyroid-stimulating hormone in any patient presenting with dyslipidemia.

cholestatic liver disease

Lipoprotein-X (an abnormal low-density lipoprotein in cholestatic conditions) plays a major role in the pathogenesis of hypercholesterolemia observed with primary biliary cirrhosis and similar hepatic disorders.

In these disorders, serum cholesterol concentrations may exceed 500 mg/dL and physical stigmata such as xanthomas may be found.

weak

cigarette smoking

Patients smoking 2 packs of cigarettes a day had a mild reduction of high-density lipoprotein cholesterol.[25] This reduction may be more pronounced in the setting of concomitant alcohol intake.[26]

It has been suggested that smoking may induce insulin resistance, with associated increases in the size and number of low-density lipoprotein and very low-density lipoprotein particles.[27]

nephrotic syndrome

Hyperlipidemia observed in patients with nephrotic syndrome is partially due to a reduction in lipid catabolism. The low oncotic pressure seen in these patients is thought to lead to increased hepatic synthesis of lipoproteins.

use of certain medications

Mild alterations of lipid metabolism can occur with drug therapy for other medical conditions. The mechanisms for this differ in each drug class.

Medications commonly implicated are high-dose thiazide diuretics, oral estrogens, glucocorticoids, anabolic steroids (also reduce high-density lipoprotein cholesterol), and atypical antipsychotics, such as olanzapine and clozapine.

The use of protease inhibitors in HIV infection is associated with a class-related side effect termed lipodystrophy syndrome, which has marked abnormalities of lipid and glucose metabolism. The acne treatment drug isotretinoin is also associated with hypercholesterolemia and hypertriglyceridemia.

Use of this content is subject to our disclaimer